HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LY103

Also Known As:

(Z)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-2-(4-((3-((4-nitrophenyl)imino)-2-oxoindolin-1-yl)methyl)-1H-1,2,3-triazol-1-yl)acetamide

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1.	Neoplasms (Cancer) 01/01/2023 - "The rational design of LY103 provided a basis for the application of nitro compounds in the treatment of hypoxic tumors and the reversal of taxol resistance." 01/01/2023 - "Concurrently, LY103 activated the immune response, reduced the expression of cytokines TNF-α, IL-6, and IL-1β, thus might be inhibit the proliferation and metastasis of tumor cells. "
2.	Neoplasm Metastasis (Metastasis) 01/01/2023 - "Concurrently, LY103 activated the immune response, reduced the expression of cytokines TNF-α, IL-6, and IL-1β, thus might be inhibit the proliferation and metastasis of tumor cells. "

Related Drugs and Biologics

1.	Paclitaxel (Taxol)
2.	Cytokines
3.	Interleukin-6 (Interleukin 6)
4.	Nitro Compounds